Hims & Hers Named to Inc.'s 2024 Best in Business List in Health Products Category
Express News | 'ADA Advises Against Using Compounded GLP-1 RA Medications' - Medscape
Hims & Hers Health Options Spot-On: On December 2nd, 106.37K Contracts Were Traded, With 583.96K Open Interest
Unusual Options Activity: AES, HIMS and Others Attract Market Bets, AES V/OI Ratio Reaches 120.0
CCORF Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Raises Target Price to $38
Express News | Canaccord Genuity Maintains Buy on Hims & Hers Health, Raises Price Target to $38
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
